3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Spinal Diseases
1
Spinal Cord Neoplasms
1
Spinal Cord Compression
1
Interventions
Temozolomide
3
veliparib
1
romidepsin
1
perillyl alcohol
1
lonafarnib
1
ispinesib
1
etoposide phosphate
1
emvododstat
1
cediranib
1
Vorinostat
1
Vincristine
1
Valproic Acid
1
Thiotepa
1
Therapeutics
1
RRx-001
1
Peripheral Blood Stem Cell Transplantation
1
N(alpha)-(4-amino-4-deoxypteroyl)-N(delta)-hemiphthaloyl-L-ornithine
1
Melphalan
1
Irinotecan
1
Infusions, Intra-Arterial
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Drug Therapy
1
Dexamethasone
1
Cyclophosphamide
1
Cisplatin
1
Carboplatin
1
Calcium Dobesilate
1
CK0238273
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Spinal Cord Neoplasms
×
Infusions, Intra-Arterial
×
Clear all
NCT01637766
2020-08-03
SIAC
Weill Medical College of Cornell University
Phase 1
Completed
12 enrolled